Follow
Ludwig G. Strauss
Ludwig G. Strauss
German Cancer Research Center
Verified email at ads-lgs.de - Homepage
Title
Cited by
Cited by
Year
The applications of PET in clinical oncology
LG Strauss, PS Conti
Journal of nuclear medicine 32 (4), 623-648, 1991
12151991
Fluorine-18 deoxyglucose and false-positive results: a major problem in the diagnostics of oncological patients
LG Strauss
European journal of nuclear medicine 23, 1409-1415, 1996
6681996
PET studies of fluorodeoxyglucose metabolism in patients with recurrent colorectal tumors receiving radiotherapy
U Haberkorn, LG Strauss, A Dimitrakopoulou, R Engenhart, F Oberdorfer, ...
Journal of Nuclear Medicine 32 (8), 1485-1490, 1991
3601991
Recurrence of colorectal tumors: PET evaluation.
LG Strauss, JH Clorius, P Schlag, B Lehner, B Kimmig, R Engenhart, ...
Radiology 170 (2), 329-332, 1989
3521989
Glucose uptake, perfusion, and cell proliferation in head and neck tumors: relation of positron emission tomography to flow cytometry
U Haberkorn, LG Strauss, CH Reisser, D Haag, A Dimitrakopoulou, ...
Journal of Nuclear Medicine 32 (8), 1548-1555, 1991
3191991
Three dimensional image correlation of CT, MR, and PET studies in radiotherapy treatment planning of brain tumors
LR Schad, R Boesecke, W Schlegel, GH Hartmann, V Sturm, LG Strauss, ...
Journal of computer assisted tomography 11 (6), 948-954, 1987
2661987
Clinical value of [18-F] fluorodeoxyglucose positron emission tomography imaging in soft tissue sarcomas
MHM Schwarzbach, A Dimitrakopoulou-Strauss, F Willeke, U Hinz, ...
Annals of surgery 231 (3), 380, 2000
2262000
Fluorodeoxyglucose imaging of advanced head and neck cancer after chemotherapy
U Haberkorn, LG Strauss, A Dimitrakopoulou, E Seiffert, F Oberdorfer, ...
Journal of Nuclear Medicine 34 (1), 12-17, 1993
1961993
Characterization of 68Ga-DOTA-D-Phe1-Tyr3-octreotide kinetics in patients with meningiomas
M Henze, A Dimitrakopoulou-Strauss, S Milker-Zabel, J Schuhmacher, ...
Journal of Nuclear Medicine 46 (5), 763-769, 2005
1942005
Comparison of the pharmacokinetics of 68Ga-DOTATOC and [18F]FDG in patients with metastatic neuroendocrine tumours scheduled for 90Y-DOTATOC therapy
S Koukouraki, LG Strauss, V Georgoulias, M Eisenhut, U Haberkorn, ...
European journal of nuclear medicine and molecular imaging 33, 1115-1122, 2006
1722006
Dynamic PET 18F-FDG studies in patients with primary and recurrent soft-tissue sarcomas: impact on diagnosis and correlation with grading
A Dimitrakopoulou-Strauss, LG Strauss, M Schwarzbach, C Burger, ...
Journal of Nuclear Medicine 42 (5), 713-720, 2001
1682001
The role of quantitative 18F-FDG PET studies for the differentiation of malignant and benign bone lesions
A Dimitrakopoulou-Strauss, LG Strauss, T Heichel, H Wu, C Burger, ...
Journal of Nuclear Medicine 43 (4), 510-518, 2002
1652002
Quantitative PET studies in pretreated melanoma patients: a comparison of 6-[18F] fluoro-L-dopa with 18F-FDG and 15O-water using compartment and noncompartment analysis
A Dimitrakopoulou-Strauss, LG Strauss, C Burger
Journal of Nuclear Medicine 42 (2), 248-256, 2001
1652001
Evaluation of the pharmacokinetics of 68Ga-DOTATOC in patients with metastatic neuroendocrine tumours scheduled for 90Y-DOTATOC therapy
S Koukouraki, LG Strauss, V Georgoulias, J Schuhmacher, U Haberkorn, ...
European journal of nuclear medicine and molecular imaging 33, 460-466, 2006
1542006
68Ga-labeled bombesin studies in patients with gastrointestinal stromal tumors: comparison with 18F-FDG
A Dimitrakopoulou-Strauss, P Hohenberger, U Haberkorn, HR Mäcke, ...
Journal of Nuclear Medicine 48 (8), 1245-1250, 2007
1302007
Prognostic significance of preoperative [18-F] fluorodeoxyglucose (FDG) positron emission tomography (PET) imaging in patients with resectable soft tissue sarcomas
MHM Schwarzbach, U Hinz, A Dimitrakopoulou-Strauss, F Willeke, ...
Annals of surgery 241 (2), 286, 2005
1202005
Evaluation of tumour metabolism and multidrug resistance in patients with treated malignant lymphomas
A Dimitrakopoulou-Strauss, LG Strauss, H Goldschmidt, WJ Lorenz, ...
European journal of nuclear medicine 22, 434-442, 1995
1201995
Prognostic aspects of 18F-FDG PET kinetics in patients with metastatic colorectal carcinoma receiving FOLFOX chemotherapy
A Dimitrakopoulou-Strauss, LG Strauss, C Burger, A Rühl, G Irngartinger, ...
Journal of Nuclear Medicine 45 (9), 1480-1487, 2004
1142004
Sunitinib in metastatic thymic carcinomas: laboratory findings and initial clinical experience
P Ströbel, R Bargou, A Wolff, D Spitzer, C Manegold, ...
British journal of cancer 103 (2), 196-200, 2010
1132010
18F‐labeled fluorouracil positron emission tomography and the prognoses of colorectal carcinoma patients with metastases to the liver treated with 5‐fluorouracil
M Moehler, A Dimitrakopoulou‐Strauss, F Gutzler, U Raeth, LG Strauss, ...
Cancer: Interdisciplinary International Journal of the American Cancer …, 1998
1041998
The system can't perform the operation now. Try again later.
Articles 1–20